Na Li

5PUBLICATIONS

10CO-AUTHORS

Molecular targetsPsychosocial aspects of childbirth and perinatal mental healthBiologically active moleculesHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|May 20, 2026

microRNA-25 drives immune checkpoint therapy resistance by repressing innate and humoral immunity via Syndecan-3.

|Sep 14, 2023

KIAA1429/VIRMA promotes breast cancer progression by m<sup>6</sup> A-dependent cytosolic HAS2 stabilization.

Na Li, Zhouting Zhu, Yufei Deng

|Mar 27, 2023

Small-molecule PTPN2 Inhibitors Sensitize Resistant Melanoma to Anti-PD-1 Immunotherapy.

Zhouting Zhu, Rachel Tang, Sarah Huff

|Feb 12, 2022

Regulation of antiviral innate immunity by chemical modification of viral RNA.

Na Li, Tariq M Rana

|Aug 05, 2020

ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment.

Na Li, Yuqi Kang, Lingling Wang

Pageof 1

Frequent Collaborators

Tariq M Rana

Zhouting Zhu

Rachel Tang

Sarah Huff

Indrasena Reddy Kummetha

Lingling Wang

Yufei Deng

Rachel Tang

Zhaoyang Jia

Jing Wen

Frequent Collaborators

Tariq M Rana

Zhouting Zhu

Rachel Tang

Sarah Huff